Baker Bros. Advisors (GP) LLC

Fund / adviser Identified by name CIK 1580575

Each row is one ownership form naming Baker Bros. Advisors (GP) LLC as an owner of a listed company’s stock.

Everything below comes from forms this entity filed with the US Securities and Exchange Commission — not an estimate, not a survey, and not a valuation.

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

20 companies it discloses a stake in
0 filings naming it as owned
17 of those stakes filed jointly

Read the share counts carefully. 17 of these 20 stakes were reported on filings shared with other entities.

What that does to the share counts

On a joint filing every named filer is listed against the whole position, so the same block of stock also appears under the other names. Adding those figures together would invent stock that does not exist. Joint positions are marked joint wherever they appear, and nothing on this site sums a position across owners.

Ownership map

What Baker Bros. Advisors (GP) LLC holds, and what those companies hold in turn. A name in plain text is the end of the trail: we hold the filing that names it, but no separate record to open.

Baker Bros. Advisors (GP) LLC
This map is not ordered by size.

It draws at most eight holdings per level and stops after two levels, showing the holdings we can follow further first, not the largest ones — for every position in order of size, read the table below. Entities that own each other are drawn once: a chain never doubles back on a name it has already passed through.

Holds stakes in

Every company this entity has filed on, largest reported position first. Each row links to the filing it came from.

Companies in which Baker Bros. Advisors (GP) LLC discloses an ownership position, with the size of that position and the filing it was taken from.
Company Reported role Shares Filed Filing
ACADIA PHARMACEUTICALS INC ACAD Director,Other,TenPercentOwner 39,468,841 joint 4
INCYTE CORP INCY Director,Other,TenPercentOwner 28,781,670 joint 4
Kodiak Sciences Inc. KOD Director,Other,TenPercentOwner 18,358,772 joint 4
Replimune Group, Inc. REPL Director,Other,TenPercentOwner 10,116,095 joint 3
Kymera Therapeutics, Inc. KYMR Director,Other,TenPercentOwner 7,955,916 joint 4
Celcuity Inc. CELC Director,Other,TenPercentOwner 7,211,484 joint 4
SERA PROGNOSTICS, INC. SERA Director,Other,TenPercentOwner 5,065,736 joint 3
Entrada Therapeutics, Inc. TRDA Director,Other,TenPercentOwner 4,691,392 joint 4
Denali Therapeutics Inc. DNLI Director,Other,TenPercentOwner 3,415,958 joint 4
Kiniksa Pharmaceuticals International, plc KNSA Director,Other,TenPercentOwner 2,753,656 joint 4
MADRIGAL PHARMACEUTICALS, INC. MDGL Director,Other,TenPercentOwner 1,947,968 joint 4
KALA BIO, Inc. KALA Director,Other,TenPercentOwner 425,006 joint 4
BeOne Medicines Ltd. ONC Director,Other,TenPercentOwner 148,070 joint 4
vTv Therapeutics Inc. VTVT Director,Other,TenPercentOwner 135,946 joint 4
IGM Biosciences, Inc. IGMS Director,Other,TenPercentOwner 0 joint 4
BICYCLE THERAPEUTICS PLC BCYC Director,Other,TenPercentOwner 4
DBV Technologies S.A. DBVT Director,Other,TenPercentOwner 4
Immunocore Holdings plc IMCR Director,Other,TenPercentOwner 4
Prelude Therapeutics Inc PRLD Director,Other,TenPercentOwner 4
TScan Therapeutics, Inc. TCRX Director,Other,TenPercentOwner 4

How to read this page

Full methodology · All entities that file as owners